The Cognitive Function and Ageing Studies (CFAS) Authorship and Publication Policy The following document is the authorship policy for CFAS. The strategy is to maximise publicity for the and also to publish in a way that recognises the depth of effort throughout the length of the study. This policy document will be distributed to all current researchers and to any researchers wishing to undertake analysis using CFAS tissue/data. Any papers will be expected to follow these guidelines before circulation to the MRC CFAS members prior to submission of the paper to journals. The document contains aspects of authorship, publicity and acknowledgements within MRC CFAS. Authorship Policy There are two situations that will arise. Main CFAS papers The original aims of the main (MRC programme grant application 1989) were to: Authorship for these aims will consist of MRC CFAS as first author together with the writing committee as currently defined for example: MRC CFAS, Able A, Bloggs B and Colleague C. Neuropathology papers The original aims of the neuropathology study (MRC special project grant application 1991) were to: Authorship for these aims will consist of MRC CFAS Neuropathology group as the first author together with the writing committee as currently defined for example: MRC CFAS Neuropathology, Able A, Blogs B and Colleague C All analysis using MRC CFAS data, blood or brain resource Authorship of papers should consist of MRC CFAS holding the "senior author" position within the paper for example: Able B, Cando D, Expert F and MRC CFAS. For both situations The address for CFAS within the paper itself would be the website address , where the existing participants and the historical contributors from each of the centres would be mentioned.
The Cognitive Function and Ageing Studies (CFAS) Authorship and Publication Policy The following document is the authorship policy for CFAS. The strategy is to maximise publicity for the and also to publish in a way that recognises the depth of effort throughout the length of the study. This policy document will be distributed to all current researchers and to any researchers wishing to undertake analysis using CFAS tissue/data. Any papers will be expected to follow these guidelines before circulation to the MRC CFAS members prior to submission of the paper to journals. The document contains aspects of authorship, publicity and acknowledgements within MRC CFAS. Authorship Policy There are two situations that will arise. Main CFAS papers The original aims of the main (MRC programme grant application 1989) were to: Authorship for these aims will consist of MRC CFAS as first author together with the writing committee as currently defined for example: MRC CFAS, Able A, Bloggs B and Colleague C. Neuropathology papers The original aims of the neuropathology study (MRC special project grant application 1991) were to: Authorship for these aims will consist of MRC CFAS Neuropathology group as the first author together with the writing committee as currently defined for example: MRC CFAS Neuropathology, Able A, Blogs B and Colleague C All analysis using MRC CFAS data, blood or brain resource Authorship of papers should consist of MRC CFAS holding the "senior author" position within the paper for example: Able B, Cando D, Expert F and MRC CFAS. For both situations The address for CFAS within the paper itself would be the website address , where the existing participants and the historical contributors from each of the centres would be mentioned.
Authorship-and-Publication-Policy-v2-01_05_2015.docx